Australia / Western Australia state guide

Peptides in Western Australia: check the ARTG and local supply record.

A Western Australia-specific peptide guide connecting national TGA product records and practitioner registration to Pharmacy Registration Board of Western Australia's official state route for pharmacy, premises, or medicines-supply claims.

Market brief

What changes in Western Australia.

In Western Australia, an Australian domain, local address, clinic page, pharmacy name, or delivery promise does not establish that a peptide product is included in the ARTG or that its supply route is supported. Pharmacy Registration Board of Western Australia provides the public premises register with pharmacy, ownership, responsibility, address, and condition details.

  • Pharmacy Registration Board of Western Australia provides the public premises register with pharmacy, ownership, responsibility, address, and condition details; use the current official route instead of a badge, screenshot, local phone number, or seller-supplied credential alone.
  • The TGA states that a research-use disclaimer does not by itself make import, manufacture, advertising, compounding, or supply of an unapproved peptide product lawful.
  • Peptide Local does not publish a Western Australia seller ranking until product category, national record, local authority route, Australian delivery, exact price, and observation date are sourced together.
Verification route

Know which record answers which question.

Local checklist

Three checks before any comparison.

Use this checklist to verify the local product, seller, and supply records before comparing price or availability.

01

Resolve the state record

Open premises register and match the legal business, premises, licence, registration, or supply category behind an offer involving Western Australia.

02

Check the exact product nationally

Search the ARTG for the product, sponsor, active ingredient, dosage form, and identifier. If no record resolves, identify the exact exemption or access pathway instead of treating a shared name as authorization.

03

Keep the supply category attached

Separate prescription medicines, pharmacy services, compounded preparations, personal imports, clinical programs, and research-labelled materials before comparing any price or availability claim.

Direct answers

What this guide can - and cannot - answer.

Each answer is tied to the local records below so you can see what is confirmed, what remains unknown, and where to recheck it. Open the primary sources ↓

01

Can every peptide offer be treated as legal to buy in Western Australia?

No blanket answer is supportable. Open premises register and match the legal business, premises, licence, registration, or supply category behind an offer involving Western Australia. In Western Australia, begin with Premises Register from Pharmacy Registration Board of Western Australia; the product, seller, and supply route still need to resolve to the same current record.

02

Does this page name the best place to buy peptides in Western Australia?

No. Peptide Local withholds a commercial table for Western Australia until seller category, local delivery, regulatory or research status, exact price, and observation date are all sourced. This page is a verification route, not a shopping recommendation.

03

Which official records should I check first in Western Australia?

For Western Australia, start with Premises Register from Pharmacy Registration Board of Western Australia, then open Searching the Australian Register of Therapeutic Goods from Therapeutic Goods Administration. The records answer separate questions, so confirm each current entry instead of treating one match as proof of the seller, product, and route together.

Compound and jurisdiction routes

Tracked peptide names in Western Australia.

Each answer preserves the compound’s research, clinical, or medicine identity, connects it to the ARTG and practitioner register when relevant, and then points to the official Western Australia route. A shared name or local record is not a blanket product, seller, legal, or availability finding.

01FDA-reviewed unapproved peptide identity

KPV in Western Australia

KPV in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
02US research-market identity

BPC-157 in Western Australia

BPC-157 in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
03US research-market identity

TB-500 in Western Australia

TB-500 in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
04US research-market identity

GHK-Cu in Western Australia

GHK-Cu in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
05US research-market identity

Semax in Western Australia

Semax in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
06US research-market identity

Melanotan II in Western Australia

Melanotan II in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
07US research-market identity

MOTS-c in Western Australia

MOTS-c in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
08US research-market identity with a separate FDA-licensed medicine record

Tesamorelin in Western Australia

Tesamorelin in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
09US research-market identity with a failed oral obesity program and no FDA-approved drug

AOD-9604 in Western Australia

AOD-9604 in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
10US research-market identity

Ipamorelin in Western Australia

Ipamorelin in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
11US research-market identity

Selank in Western Australia

Selank in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
12US research-market identity with a separate FDA-approved medicine record

PT-141 / Bremelanotide in Western Australia

PT-141 / Bremelanotide in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
13US research-market identity

CJC-1295 no DAC in Western Australia

CJC-1295 no DAC in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
14US research-market identity

CJC-1295 DAC in Western Australia

CJC-1295 DAC in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
15Investigational clinical program

Retatrutide in Western Australia

Retatrutide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
16China-approved medicine and active clinical program

Mazdutide in Western Australia

Mazdutide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
17China-approved medicine and active development program

Ecnoglutide in Western Australia

Ecnoglutide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
18Investigational clinical program

Enicepatide in Western Australia

Enicepatide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
19Investigational clinical program

Eloralintide in Western Australia

Eloralintide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
20Investigational clinical program

Cagrilintide in Western Australia

Cagrilintide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
21Investigational clinical program

Petrelintide in Western Australia

Petrelintide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
22Investigational clinical program

CagriSema in Western Australia

CagriSema in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
23Investigational clinical program

MariTide in Western Australia

MariTide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
24Investigational clinical program

Survodutide in Western Australia

Survodutide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
25Investigational clinical program

VK2735 in Western Australia

VK2735 in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
26Investigational clinical program

Pemvidutide in Western Australia

Pemvidutide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
27Investigational clinical program

Amycretin / Zenagamtide in Western Australia

Amycretin / Zenagamtide in Western Australia refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
28US FDA medicine reference

Tirzepatide in Western Australia

Tirzepatide in Western Australia begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
29FDA-approved US medicine with country-specific status elsewhere

Orforglipron / Foundayo in Western Australia

Orforglipron / Foundayo in Western Australia begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
30Product-specific approved medicine records in multiple jurisdictions

Semaglutide in Western Australia

Semaglutide in Western Australia begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
31FDA-flagged unapproved research-market peptide identity

DSIP / Emideltide in Western Australia

DSIP / Emideltide in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
32US research-market identity

IGF-1 LR3 in Western Australia

IGF-1 LR3 in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
33US research-market identity

Kisspeptin-10 / KP-10 in Western Australia

Kisspeptin-10 / KP-10 in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
34US research-market identity separated from SCENESSE

Melanotan I in Western Australia

Melanotan I in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
35US research-market non-peptide coenzyme identity

NAD+ in Western Australia

NAD+ in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
36US research-market identity with a withdrawn historical medicine record

Sermorelin in Western Australia

Sermorelin in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
37No FDA-approved US product; exact foreign prescription products exist

Thymosin Alpha-1 in Western Australia

Thymosin Alpha-1 in Western Australia begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
38FDA-approved US medicine with a withdrawn EU application

EGRIFTA WR in Western Australia

EGRIFTA WR in Western Australia begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
39Product-specific FDA and EU medicine records

Liraglutide in Western Australia

Liraglutide in Western Australia begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
40Product-specific FDA and EU medicine records

SCENESSE in Western Australia

SCENESSE in Western Australia begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
41Product-specific FDA-approved US medicine record

VYLEESI in Western Australia

VYLEESI in Western Australia begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Western Australia, open Premises Register from Pharmacy Registration Board of Western Australia and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routePremises RegisterPharmacy Registration Board of Western Australia
00
Publishing gate

No commercial price table yet.

Peptide Local will not manufacture a ranking from thin data. A local table appears only after seller category, authorization or research status, delivery market, price, and source date can all be stated clearly.

Primary sources

Repeat the checks yourself.

Official sources are linked directly. Open them to confirm the current record; this page is a guide, not a substitute for the regulator.

Related guides